Mechanistic and inhibition studies on isocitrate dehydrogenase 1
<p>Genes encoding for IDH1 and IDH2 are frequently mutated in multiple cancer types including gliomas and AML. IDH variants, notably R132H IDH1, result in a gain-offunction leading to substantially enhanced production of the ‘oncometabolite’, 2- hydroxyglutarate. Drug development by pharmaceut...
第一著者: | Liu, S |
---|---|
その他の著者: | Schofield, C |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2019
|
類似資料
-
The studies on the mechanism and inhibition of Isocitrate Dehydrogenases
著者:: Liu, X
出版事項: (2022) -
Differentiating inhibition selectivity and binding affinity of isocitrate dehydrogenase 1 variant inhibitors
著者:: Liu, S, 等
出版事項: (2023) -
Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
著者:: Liu, S, 等
出版事項: (2021) -
Studies on human cancer variant and mycobacterial isocitrate dehydrogenases
著者:: Reinbold, R
出版事項: (2021) -
Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
著者:: Liu, S, 等
出版事項: (2020)